Why the study?
Does stress echocardiography reduce costs compared to myocardial perfusion scintigraphy and coronary angiography in patients with chest pain unsuitable for exercise treadmill testing?
Does stress echocardiography reduce costs compared to myocardial perfusion scintigraphy and coronary angiography in patients with chest pain unsuitable for exercise treadmill testing?
Stress echocardiography provides significant cost savings compared to myocardial perfusion scintigraphy and coronary angiography for evaluating low-to-intermediate risk chest pain in a district hospital setting.
May support cost savings with stress echocardiography for chest pain; leaves open need for randomized confirmation versus alternatives.
AIMS: Accurate and cost-effective techniques are required for investigating patients experiencing chest pain, given the significant workload this patient cohort represents. We determined the cost impact of stress echocardiography compared with myocardial perfusion scintigraphy and coronary angiography in the investigation of patients with chest pain deemed unsuitable for exercise treadmill testing. METHODS AND RESULTS: A total of 200 patients with chest pain-with a low-intermediate probability of coronary artery disease-consecutively referred for stress echocardiography were recruited. Referring clinicians were asked which management strategy they would have chosen were the stress echocardiography service unavailable. The cost saving of stress echocardiography, an accuracy analysis, and adverse outcomes at 6 and 24 months follow-up were determined. The total cost attributable to the stress echocardiography service was Pound Sterling 58 368. If unavailable, 78 (39%) patients would have been referred for angiography and 122 (61%) for perfusion scintigraphy at a cost of Pound Sterling 56 316 and Pound Sterling 42 090, respectively, with a total cost of Pound Sterling 98 406. This represents a cost saving of Pound Sterling 40 038. CONCLUSION: Stress echocardiography is a cost saving method for the investigation of chest pain in patients with low-intermediate risk of flow limiting coronary artery disease in the district hospital setting.
No takes yet. Share an insight, caveat, or question.
Wennike et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: